HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

STXS

Stereotaxis, Inc. (AMEX)

Healthcare — Medical Instruments & Supplies

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as Genesis RMN, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN System, which is designed to enhance the accessibility of Robotic Magnetic Navigation by reducing the lengthy construction cycle necessary to install prior generation RMN systems. It also offers Odyssey, a Synchrony and SynX Solution offer integrated, real-time information solution to manage, control, record and share procedures across networks; and x-ray systems. In addition, the company offers disposables and other accessories, including MAGiC catheter, a robotically navigated magnetic ablation catheter designed to perform minimally invasive cardiac ablation procedures; MAGiC Sweep, a mapping catheter; QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; and V-CAS devices. Further, it provides interventional devices under the Map-iT, MAGiC, and EMAGIN brands, and other related devices. It markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.

Strong Buy 1.5 / 5 4 analysts
$1.77
+$0.05 (+2.91%)
Target: $4.13 (133.1%)
Sign in to add STXS to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$172.99M
P/E Ratio (TTM)-
Forward P/E-13.97
EPS (TTM)$-0.24
Dividend Yield-
Profit Margin-69.50%
Revenue Growth-15.80%
ROE-156.12%
Debt/Equity26.94
Recommendation Strong Buy 1.5
Analyst Target$4.13
Analysts4
Indexes AMEX

Technical Indicators

RSI (14)46.8
Beta1.33
SMA 20-
SMA 40-
52-Week High$3.59
52-Week Low$1.59
50-Day Avg$1.86
200-Day Avg$2.29
Avg Volume437.4K
Volume2.9K

Performance Analysis

NEUTRAL

STXS presents a mixed picture with both positive and negative indicators.

+ Trading near its 52-week low ($1.59), which could present a value opportunity.
~ RSI at 46.8 is in neutral territory.
- Price is below both the 50-day and 200-day moving averages — in a downtrend.
- Revenue declined 15.8% year-over-year.
- Operating at a loss with -69.5% margin.
+ Wall Street consensus is "Strong Buy" from 4 analysts.
+ Average analyst target of $4.12 implies 133.1% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:33 UTC

Back to Screener Export Report